I G I (AMEX:IG)
Historical Stock Chart
3 Years : From Jun 2010 to Jun 2013
TriPoint Global Research publishes Research Report on IGI, Laboratories,
Inc. (Amex: IG) by Senior Analysts Richard W West, CFA and Sherry
Grisewood, CFA
-
Industry: Pharmaceuticals & Biotechnology
-
Current Rating: Market Perform
-
Rating Assigned: 6/14/2011
-
Analyst: Richard W West, CFA and Sherry Grisewood, CFA
A 23-page Research Report is available for download at http://www.tripointglobalresearch.com/current-research.php,
as well as other leading financial portals, that include Reuters,
Capital IQ and Research Direct on Bloomberg terminals by entering TRPN.
About IGI, Laboratories, Inc.
IGI, Laboratories, Inc. is a topical pharmaceuticals and OTC products
manufacturer primarily engaged in the production and packaging of
formulations and agents used in pharmaceuticals, cosmetics, and consumer
skin care products. IGI’s expertise lies in the development,
formulation, turnkey manufacturing, filling and packaging of topical
semi-solid, suspension and liquid products, many of which incorporate
novel encapsulation and delivery technologies.
About TriPoint Global Research, LLC:
TriPoint Global Research, LLC is an independent investment research
firm. Its senior analysts are primarily CFAs, and have expertise in many
industries. A TriPoint Global Research, LLC research report or note is
not intended as an offering or a solicitation of an offer to buy or sell
the securities mentioned or discussed. Neither the firm, its principals
nor the assigned analysts own or trade shares of any company covered.
The firm does not accept any equity compensation. Anyone may enroll a
company for research coverage, which currently costs US $30,000 prepaid
for three research reports, typically published quarterly, and requisite
research notes. TriPoint Global Research, LLC received $30,000 from the
company for three research reports with coverage commencing on October
17, 2009.
| 
